Dermatology News

The American Academy of Dermatology Association and American Society for Dermatologic Surgery Association have released official statements in response to reports of patients being hospitalized for botulism from counterfeit Botox injections.

An investigation of mpox cases during a 2023 outbreak revealed that cases were likely due to frequent behaviors associated with mpox transmission despite most patients being vaccinated with a relatively highly effective vaccine.

The FDA has granted emergency use authorization for Labcorp’s Mpox PCR Test Home Collection Kit, the company announced in a press release.

Only half of rheumatologists are “extremely comfortable” prescribing the Humira biosimilar Amjevita, while just 16% can say the same for all other adalimumab biosimilars combined, according to a market analysis from Spherix Global Insights.

Rheumatologists should turn to biologics as usual treatment in patients with psoriatic arthritis who demonstrate an inadequate response to methotrexate, according to new EULAR recommendations.

Health officials identified a cluster of cases of feline sporotrichosis, as well as zoonotic transmission between one of the infected cats and a veterinary technician at a clinic in Kansas.

Aruba Aloe Balm N.V. has recalled 40 lots of its hand sanitizer and aloe products due to methanol contamination, according to an FDA public service announcement.

Patients with psoriatic arthritis who use guselkumab are more likely to experience meaningful improvements in fatigue and pain if they achieve resolution of enthesitis or dactylitis, according to data published in Clinical Rheumatology.

The FDA this week approved the antibiotic Zevtera for the treatment of three bacterial infections 17 years after it was first submitted to the agency.

When viewing the solar eclipse on April 8, individuals in the United States should not only protect their eyes, but also their skin.